Benten BioServices

Malvern, United States Founded: 2008 • Age: 18 yrs Acquired By Deltagen
Biological safety testing and biomanufacturing services are offered for biopharmaceuticals.

About Benten BioServices

Benten BioServices is a Healthcare company based in Malvern (United States) founded in 2008, and was acquired by Deltagen in December 2009. Biological safety testing and biomanufacturing services are offered for biopharmaceuticals. Benten BioServices has raised $8.1 million across 5 funding rounds from investors including LSG Investments, Penn Venture Partners and Deltagen. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its competitors include BioAgilytix, Advion and Evans Analytical Group; 1 of its 3 listed competitors has raised funding.

Company details

Benten BioServices was founded in 2008 and operates as a contract services organization in the biotechnology and pharmaceutical sectors. Regulatory-compliant manufacturing and testing services are provided to support biopharmaceutical development and commercialization. These include biosafety and raw materials testing, assay and process validation, cell banking and characterization, filling and packaging, as well as pre-clinical development, CRO support, and RD consulting. The company is based in Malvern, United States.

  • Headquarters Malvern, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website bentenbio.com
  • Acquired by Deltagen (Dec 2009)
Key Metrics
  • Total Equity Funding
    $8.1M (USD)

    in 5 rounds

  • Latest Funding Round
    $78.5K (USD), Debt – Conventional

    May 2013

  • Investors
  • Acquired by
    Deltagen

    (Dec 2009)

Funding Insights of Benten BioServices

Benten BioServices has successfully raised a total of $8.1M across 5 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $78.5 thousand completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $8.1M
  • Total Rounds 5
  • Last Round Debt – Conventional β€” $78,500
  • First Round $2.74M

    (Dec 2011)

  • Investors Count 2

All 5 funding rounds of Benten BioServices with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2013$78,500Debt – Conventional––
–
Jan 2013$1.32MSeries A––
Oct 2012$1.1MSeries A––
–
Aug 2012$2.94MSeries A–LSGPA, Penn Venture Partners
–
Dec 2011$2.74MSeed––
–
Valuation history

3 investors in total: 3 institutional.

Investors in Benten BioServices

Benten BioServices has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include LSG Investments, Penn Venture Partners and Deltagen.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Early-stage investments are made in life sciences technologies.
lsgpa.comHarrisburg, United States
pennventures.com
Provides drug discovery tools and services to the biopharmaceutical industry.
1997deltagen.comSan Mateo, United States
Premium access

Investor details for Benten BioServices

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Benten BioServices

4 dated milestones of Benten BioServices across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Benten BioServices is founded.
  2. Exit Acquired by Deltagen.
  3. Funding First funding round of $2.7M.
  4. Funding Latest funding round, Debt – Conventional, of $78K.

Competitors of Benten BioServices

Benten BioServices has 3 listed competitors in our database, 1 of them funded. They include BioAgilytix, Advion and Evans Analytical Group.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bioagilytix.com2008Durham, United States446
Large-molecule bioanalysis is provided for biologics and biosimilars development.
advion.com1993Ithaca, United States$45.64M54
Microfluidics and mass spectrometry products are provided for clinical research.
eag.com1978San Diego, United States601
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
Premium access

Detailed competitors of Benten BioServices

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Benten BioServices (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Benten BioServices

Benten BioServices was founded in 2008 and raised its 1st funding round 3 years after it was founded.

Benten BioServices is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania, United States.

Benten BioServices is a funded company, having raised a total of $8.1M across 5 funding rounds to date. The company's 1st funding round was a Seed of $2.74M, raised on Dec 2011.

Benten BioServices was founded in 2008 and operates as a contract services organization in the biotechnology and pharmaceutical sectors. Regulatory-compliant manufacturing and testing services are provided to support biopharmaceutical development and commercialization. These include biosafety and raw materials testing, assay and process validation, cell banking and characterization, filling and packaging, as well as pre-clinical development, CRO support, and RD consulting. The company is based in Malvern, United States.

Benten BioServices's top competitors include BioAgilytix, Advion and Evans Analytical Group.

Benten BioServices has 3 investors. Key investors include LSG Investments, Penn Venture Partners, and Deltagen.

Yes. Benten BioServices was acquired by Deltagen in December 2009.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available